Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day. More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund. More
Dr. David Hill, Scientific Director of the lawson health research Institute has been honoured with the 2009 Federick G. Banting Award for his significant contributions to preventing diabetes in Canada. More
Probiodrug AG grants Ferring BV and its sublicensee, Ortho-McNeil Pharmaceuticals, a Johnson & Johnson company, a non-exclusive license to develop inhibitors of dipeptidyl peptidase IV (DP IV). More
Lawson Health Research Institute partners with MedManager to evaluate patient portals for cardiac rehabilitation, diabetes, and prostate cancer clinics More
Published each fall since 2003, Robarts' annual magazine explores and celebrates our people, our place, and, most importantly, our science in an engaging, inspiring, and accessible style. More
Morphochem AG and Xenogen Corp. today announced that both companies have entered into a research collaboration to discover targets and develop compounds effective against bacterial biofilms. More
Reddy US Therapeutics, Inc a biopharmaceutical company in suburban Atlanta, and a subsidiary of Dr. Reddy's Laboratories Limited announced today the appointment of Dr. Bruce Carter to its Board of Directors More